Colorectal Cancer Clinical Trials in Tampa, FL

Colorectal Cancer Clinical Trials in Tampa, FL

View the best 10 colorectal cancer medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in Tampa, Florida

Here are the top 10 medical studies for colorectal cancer in Tampa, Florida

Image of Highlands Oncology Group, PA in Fayetteville, United States.

PF-07799544

Chemotherapy

Recruiting1 awardPhase 1
This trial is studying a new medicine (PF-07799544) to treat advanced solid tumors. Participants will receive the medicine and possibly other treatments. They'll be monitored by the study team during regular visits.
Image of Exelixis Clinical Site #53 in Gilbert, United States.

Cabozantinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing the safety and effectiveness of a new cancer drug when used in combination with another cancer drug. The new drug is being tested on people with different types of cancer, including bladder, kidney, prostate, and breast cancer.
Image of Investigational Site Number :8400007 in Duarte, United States.

SAR444245 +2 More

Interleukin-2 (IL-2) Agonist

Recruiting1 awardPhase 2
This trial is a phase 2 study investigating the efficacy of SAR444245 in combination with other cancer treatments for patients with advanced gastrointestinal cancer. The study is composed of four sub-studies, each investigating the combination of SAR444245 with a different treatment for a different type of gastrointestinal cancer. The primary outcome measure for each sub-study is the percentage of patients experiencing an objective response.
Image of University of South Florida in Tampa, United States.

Nonessential Amino Acid Restriction (NEAAR) Medical Food

Recruiting1 award7 criteria
This trial will test whether a special diet supplement is safe and well-tolerated for adult patients with advanced rectal cancer who are undergoing radiation therapy and chemotherapy.
Image of Highlands Oncology in Springdale, United States.

Fruquintinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, fruquintinib, to see if it is safe and effective when used with tislelizumab to treat patients with locally advanced or metastatic solid tumors. The trial will be conducted in two parts; a Safety Lead-in Phase (Part 1) and a Dose Expansion Phase (Part 2). Part 1 will be open to any-comer solid tumors and will determine the Recommended Phase 2 Dose (RP2D). The RP2D will be administered to four cohorts of patients in Part 2.
Image of Mary Crowley Cancer Research in Dallas, United States.

CTX-009

Chemotherapy

Recruiting1 awardPhase 2
This trial studies a potential new treatment for metastatic colorectal cancer, enrolling up to 84 patients. Results may provide better care for those with the disease.
Image of University of California Los Angeles (UCLA). in Los Angeles, United States.

COM701

Recruiting1 awardPhase 1
This trial is testing a new cancer drug to see if it is safe and effective.
Image of UC San Diego Moores Cancer Center in San Diego, United States.

XmAb®23104

Monoclonal Antibodies

Recruiting2 awardsPhase 1
This trial is testing a new drug, XmAb23104, to see if it is safe and effective at treating advanced solid tumors.
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

E7386

Microtubule Inhibitor

Recruiting1 awardPhase 1
This trialtests a new drug to treat cancer and check if it's safe and effective.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Quality-of-Life Assessment

Recruiting0 awardsPhase 2 & 3
This trial is testing duloxetine to see if it can help prevent pain, tingling, and numbness caused by oxaliplatin in patients with colorectal cancer.

Popular filter options for colorectal-cancer tampa trials

Phase 3 Clinical Trials

View 77 phase 3 medical studies.

Clinical Trials With No Placebo

View 77 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.